GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 22, 2025 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
8DNR | O89342 | Prefusion-stabilized Hendra virus fusion protein | |
8DNG | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein | |
7UPB | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1H1 | |
7UPB | 7UPB | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1H1 | |
7UPA | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1H8 | |
7UPA | 7UPA | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1H8 | |
7UPD | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2B12 | |
7UPD | 7UPD | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2B12 | |
7UP9 | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2D3 | |
7UP9 | 7UP9 | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2D3 | |
7UOP | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 4H3 | |
7UOP | 7UOP | Prefusion-stabilized Nipah virus fusion protein complexed with Fab 4H3 | |
8U1G | P0DTC2 | Prefusion-stabilized SARS-CoV-2 S2 subunit | |
8CW9 | H6X1Z0 | Prefusion-stabilized hMPV fusion protein bound to ADI-61026 and MPE8 Fabs | |
8CW9 | 8CW9 | Prefusion-stabilized hMPV fusion protein bound to ADI-61026 and MPE8 Fabs | |
9CTH | P12259 | Preliminary map of the Prothrombin-prothrombinase complex on nano discs | |
9CTH | P00742 | Preliminary map of the Prothrombin-prothrombinase complex on nano discs | |
9CTH | P00734 | Preliminary map of the Prothrombin-prothrombinase complex on nano discs | |
4KI1 | P01854 | Primitive triclinic crystal form of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23 | |
4KI1 | P06734 | Primitive triclinic crystal form of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23 | |
4YCG | Q9WV56 | Pro-bone morphogenetic protein 9 | |
4YCG | Q9UK05 | Pro-bone morphogenetic protein 9 | |
3S1E | Q9T0N8 | Pro427Gln mutant of maize cytokinin oxidase/dehydrogenase complexed with N6-isopentenyladenine | |
3QPK | Q70KY3 | Probing oxygen channels in Melanocarpus albomyces laccase | |
1MFU | P04745 | Probing the role of a mobile loop in human salivary amylase: Structural studies on the loop-deleted mutant | |
1MFV | P04745 | Probing the role of a mobile loop in human slaivary amylase: Structural studies on the loop-deleted enzyme | |
3DHP | P04745 | Probing the role of aromatic residues at the secondary saccharide binding sites of human salivary alpha-amylase in substrate hydrolysis and bacterial binding | |
7POI | O95393 | Prodomain bound BMP10 crystal form 1 | |
7POJ | O95393 | Prodomain bound BMP10 crystal form 2 | |
4H45 | P00636 | Product Complexes of Porcine Liver Fructose-1,6-bisphosphatase with Mutation E192Q | |
4GX3 | P00636 | Product Complexes of Porcine Liver Fructose-1,6-bisphosphatase with mutation R22M Reveal a T-state Conformation | |
2YA1 | Q97SQ7 | Product complex of a multi-modular glycogen-degrading pneumococcal virulence factor SpuA | |
6T2Q | A5ZIF0 | Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown | |
6T2S | A0A3E5CV05 | Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown | |
1YBW | Q04756 | Protease domain of HGFA with no inhibitor | |
7EOX | 7EOX | Protease structure from Euphorbia resinifera | |
3ICU | Q8TEB7 | Protease-associated domain of the E3 ligase grail | |
3VKM | O00214 | Protease-resistant mutant form of Human Galectin-8 in complex with sialyllactose and lactose | |
3VKL | O00214 | Protease-resistant mutant form of human Galectin-8 in complex with two lactose molecules | |
8VIA | P0DTC2 | Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination | |
8VIA | 8VIA | Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination | |
2H6F | P49354 | Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution | |
2H6F | P49356 | Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution | |
2H6F | 2H6F | Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution | |
1TN6 | P49354 | Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution | |
1TN6 | P49356 | Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution | |
1TN6 | 1TN6 | Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution | |
4GG6 | P01909 | Protein complex | |
4GG6 | P01920 | Protein complex | |
4GG6 | 4GG6 | Protein complex |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024